OTCMKTS:RBOT Vicarious Surgical (RBOT) Stock Price, News & Analysis $0.0002 0.00 (-50.00%) As of 10/21/2026 02:32 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About Vicarious Surgical Stock (OTCMKTS:RBOT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Vicarious Surgical alerts:Sign Up Key Stats Today's Range$0.00▼$0.2550-Day Range$0.02▼$0.2652-Week Range$0.00▼$6.28Volume46,589 shsAverage Volume44,397 shsMarket Capitalization$1.42 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingReduce Company Overview Vicarious Surgical, Inc. is a technology company developing robotic-assisted surgical systems. Its principal product is the Vicarious Surgical System, a single-port robotic platform designed to enable surgeons to perform minimally invasive procedures through a small incision. The system combines miniature instruments, a high-resolution camera and digital controls intended to provide surgeons with an immersive view of the operating field and precise instrument control. The company’s technology is aimed initially at general surgery applications, including procedures performed within the abdominal cavity. Vicarious Surgical has focused on developing a compact robotic system that can provide multi-axis instrument movement and visualization while potentially reducing the size and complexity of surgical access. Its products remain subject to regulatory review and authorization, and the company’s activities have primarily involved research, development and clinical evaluation rather than broad commercial deployment. Vicarious Surgical was founded in 2014 and became a publicly traded company in 2021 through a business combination with D8 Holdings Corp. The company is based in Waltham, Massachusetts, and has concentrated its regulatory and development efforts in the United States. Co-founder Adam Sachs has served as the company’s chief executive officer and has been involved in guiding the development of its robotic surgery platform. AI Generated. May Contain Errors. Read More Vicarious Surgical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks9th Percentile Overall ScoreRBOT MarketRank™: 0.460561497325 of 5 starsVicarious Surgical scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.8 / 5Analyst RatingReduce Consensus RatingVicarious Surgical has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageVicarious Surgical has received no research coverage in the past 90 days.Read more about Vicarious Surgical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioVicarious Surgical has a P/B Ratio of 0.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Vicarious Surgical's valuation and earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for RBOT. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldVicarious Surgical does not currently pay a dividend.Dividend GrowthVicarious Surgical does not have a long track record of dividend growth. News and Social Media2.9 / 5News SentimentN/A News SentimentVicarious Surgical has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Vicarious Surgical this week, compared to 1 article on an average week.Search Interest1 people have searched for RBOT on MarketBeat in the last 30 days. Company Ownership1.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Vicarious Surgical insiders have not sold or bought any company stock.Percentage Held by Insiders11.11% of the stock of Vicarious Surgical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions47.27% of the stock of Vicarious Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Vicarious Surgical's insider trading history. Receive RBOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RBOT Stock News HeadlinesVicarious Surgical (NYSE:RBOT) Shares Climb 1,200% - Here's WhyOctober 21 at 2:01 AM | americanbankingnews.comSS Innovations names Sarah Romano as CFOJuly 15, 2026 | finance.yahoo.com80 Days Until the Pentagon Restricts Chinese Rare EarthsChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports to the U.S. With a January 1, 2027 deadline approaching, the Pentagon selected four companies to build critical mineral processing facilities on U.S. military bases. Only one was chosen for heavy rare earths - a Nasdaq-listed firm with an Ohio metallurgy facility under Pentagon contracts and rights to 80% of output from a major Canadian processing plant. | The Tomorrow Investor (Ad)Vicarious Surgical board proposes dissolving the companyJuly 15, 2026 | finance.yahoo.comVicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical SettingMay 13, 2026 | globenewswire.comVicarious Surgical Reports First Quarter 2026 Financial ResultsApril 30, 2026 | globenewswire.comVicarious Surgical Shareholders Approve Reverse Stock Split AuthorizationApril 8, 2026 | tipranks.comVicarious Surgical, Inc. Class AApril 7, 2026 | edition.cnn.comSee More Headlines RBOT Stock Analysis - Frequently Asked Questions How have RBOT shares performed this year? Vicarious Surgical's stock was trading at $2.16 at the beginning of 2026. Since then, RBOT stock has decreased by 100.0% and is now trading at $0.0002. How were Vicarious Surgical's earnings last quarter? Vicarious Surgical Inc. (OTCMKTS:RBOT) posted its quarterly earnings results on Monday, March, 9th. The company reported ($1.65) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.37) by $0.28. When did Vicarious Surgical's stock split? Shares of Vicarious Surgical reverse split before market open on Thursday, June 13th 2024.The 1-30 reverse split was announced on Thursday, June 13th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 13th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. How do I buy shares of Vicarious Surgical? Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Vicarious Surgical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Vicarious Surgical investors own include NVIDIA (NVDA), Editas Medicine (EDIT), Heron Therapeutics (HRTX), Advanced Micro Devices (AMD), Tesla (TSLA), Super Micro Computer (SMCI) and Aktis Oncology (AKTS). Company Calendar Last Earnings3/09/2026Today10/21/2026Next Earnings (Estimated)11/17/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolOTCMKTS:RBOT Previous SymbolNYSE:RBOT CIK1812173 Webwww.vicarioussurgical.com Phone617 868 1700FaxN/AEmployees48Year Founded2014Profitability EPS (Trailing Twelve Months)($6.69) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$50.18 million Net MarginsN/A Pretax MarginN/A Return on Equity-340.15% Return on Assets-167.95% Debt Debt-to-Equity RatioN/A Current Ratio1.54 Quick Ratio1.54 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.38 per share Price / Book0.00Miscellaneous Outstanding Shares7,120,000Free Float6,333,000Market Cap$1.42 thousand OptionableNo Data Beta2.15 Social Links 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (OTCMKTS:RBOT) was last updated on 10/21/2026 by MarketBeat.com Staff. From Our PartnersMicroscopic footage reveals immune cells destroying cancer cellsTime-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer ce...Market Tactic | Sponsored80 Days Until the Pentagon Restricts Chinese Rare EarthsChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vicarious Surgical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vicarious Surgical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
